Home > > > Report Detail

Global (United States, European Union and China) Bio-Therapeutic Glycoproteins Market Research Report 2019-2025

Publisher Name :
Date: 18-Jul-2019
No. of pages: 110
Inquire Before Buying

Bio-Therapeutic Glycoproteins are bioactive compounds with carbohydrates attached to proteins. Glycan is the specific site where carbohydrate attaches to proteins and process of production is called glycosylation. Bio-therapeutic glycoproteins produced with glycan moieties that are similar to natural mammal glycans. The most common types are glycosylation O-linked and N-linked that are mainly depends on protein sequence attachment. Carbohydrates linked to proteins through either a and ß linkages. Glycosylation is an important process of bio-therapeutic glycoproteins because it is critically modulated into bioactivity, stability, solubility against proteolysis, yield, clearance rate from circulation and immunogenicity. The bio-therapeutic glycoproteins mainly produced by yeast expression systems, insect cells, mammalian systems, and plant-based expression systems. In yeast expression systems, yeast is cultured chemically to scale up fermentation to an industrial level. Yeast and human share same N-glycan's linkage. Insect cells represent an alternative system for expression of recombinant bio-therapeutic proteins. Later recombinant proteins are separated from insect cells. Mammalian Systems are used to produce complex bio-therapeutic glycoproteins. Most of the FDA approved bio-therapeutic glycoproteins derived from mammalian systems. Plant-based expression systems used for the scale-up production of glycoproteins. Among all systems, mammalian systems are well established in pharmaceuticals. Some examples of bio-therapeutic glycoproteins include tocilizumab, bevacizumab, adalimumab, etc.

The potential benefits of Bio-Therapeutic Glycoproteins have been a subject of rising industrial interest in the context of wide range application. So, far they include several protein classes like antisera, cytokines, clotting factors, hormones, enzymes and enzyme inhibitors have been best suited physiologically. The trend of industrial developments likely continues alongside with growing knowledge about the functions of bio-therapeutic glycoproteins. Bio-Therapeutic Glycoproteins are a fastest growing field in the pharmaceutical industry due to a wide range of applicability. The mammalian expression system is used to produce glycoproteins that coded with human-like glycans. Bio-Therapeutic glycoproteins represent an integrated treatment for most of the autoimmune disorders, cancers, replacement therapies like hormone and enzyme substituted. All these benefits of glycoproteins drive the robust growth of the Bio-Therapeutic Glycoproteins market.

In 2019, the market size of Bio-Therapeutic Glycoproteins is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bio-Therapeutic Glycoproteins.

This report studies the global market size of Bio-Therapeutic Glycoproteins, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Bio-Therapeutic Glycoproteins sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Genentech

- Hoffmann-La Roche

- Genzyme Corp

- Abbott Laboratories

- Amgen

- Biogen

- Merck

- GlaxoSmithKline

- Novartis Pharmaceuticals Corp

Market Segment by Product Type

- Antisera

- Cytokines

- Clotting Factors

- Hormones

- Enzymes

- Enzyme Inhibitors

Market Segment by Application

- Oncology and Haematology

- Diabetes

- Cardiology

- Inflammatory Diseases

- Others

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Bio-Therapeutic Glycoproteins status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Bio-Therapeutic Glycoproteins manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Bio-Therapeutic Glycoproteins are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Bio-Therapeutic Glycoproteins Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Bio-Therapeutic Glycoproteins Market Size Growth Rate by Type (2019-2025)
1.3.2 Antisera
1.3.3 Cytokines
1.3.4 Clotting Factors
1.3.5 Hormones
1.3.6 Enzymes
1.3.7 Enzyme Inhibitors
1.4 Market Segment by Application
1.4.1 Global Bio-Therapeutic Glycoproteins Market Share by Application (2019-2025)
1.4.2 Oncology and Haematology
1.4.3 Diabetes
1.4.4 Cardiology
1.4.5 Inflammatory Diseases
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio-Therapeutic Glycoproteins Market Size
2.1.1 Global Bio-Therapeutic Glycoproteins Revenue 2014-2025
2.1.2 Global Bio-Therapeutic Glycoproteins Sales 2014-2025
2.2 Bio-Therapeutic Glycoproteins Growth Rate by Regions
2.2.1 Global Bio-Therapeutic Glycoproteins Sales by Regions 2014-2019
2.2.2 Global Bio-Therapeutic Glycoproteins Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Bio-Therapeutic Glycoproteins Sales by Manufacturers
3.1.1 Bio-Therapeutic Glycoproteins Sales by Manufacturers 2014-2019
3.1.2 Bio-Therapeutic Glycoproteins Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Bio-Therapeutic Glycoproteins Revenue by Manufacturers (2014-2019)
3.2.2 Bio-Therapeutic Glycoproteins Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Bio-Therapeutic Glycoproteins Market Concentration Ratio (CR5 and HHI)
3.3 Bio-Therapeutic Glycoproteins Price by Manufacturers
3.4 Key Manufacturers Bio-Therapeutic Glycoproteins Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Bio-Therapeutic Glycoproteins Market
3.6 Key Manufacturers Bio-Therapeutic Glycoproteins Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Antisera Sales and Revenue (2014-2019)
4.1.2 Cytokines Sales and Revenue (2014-2019)
4.1.3 Clotting Factors Sales and Revenue (2014-2019)
4.1.4 Hormones Sales and Revenue (2014-2019)
4.1.5 Enzymes Sales and Revenue (2014-2019)
4.1.6 Enzyme Inhibitors Sales and Revenue (2014-2019)
4.2 Global Bio-Therapeutic Glycoproteins Sales Market Share by Type
4.3 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type
4.4 Bio-Therapeutic Glycoproteins Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Bio-Therapeutic Glycoproteins Sales by Application
6 United States
6.1 United States Bio-Therapeutic Glycoproteins Breakdown Data by Company
6.2 United States Bio-Therapeutic Glycoproteins Breakdown Data by Type
6.3 United States Bio-Therapeutic Glycoproteins Breakdown Data by Application
7 European Union
7.1 European Union Bio-Therapeutic Glycoproteins Breakdown Data by Company
7.2 European Union Bio-Therapeutic Glycoproteins Breakdown Data by Type
7.3 European Union Bio-Therapeutic Glycoproteins Breakdown Data by Application
8 China
8.1 China Bio-Therapeutic Glycoproteins Breakdown Data by Company
8.2 China Bio-Therapeutic Glycoproteins Breakdown Data by Type
8.3 China Bio-Therapeutic Glycoproteins Breakdown Data by Application
9 Rest of World
9.1 Rest of World Bio-Therapeutic Glycoproteins Breakdown Data by Company
9.2 Rest of World Bio-Therapeutic Glycoproteins Breakdown Data by Type
9.3 Rest of World Bio-Therapeutic Glycoproteins Breakdown Data by Application
9.4 Rest of World Bio-Therapeutic Glycoproteins Breakdown Data by Countries
9.4.1 Rest of World Bio-Therapeutic Glycoproteins Sales by Countries
9.4.2 Rest of World Bio-Therapeutic Glycoproteins Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Genentech
10.1.1 Genentech Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
10.1.4 Bio-Therapeutic Glycoproteins Product Introduction
10.1.5 Genentech Recent Development
10.2 Hoffmann-La Roche
10.2.1 Hoffmann-La Roche Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
10.2.4 Bio-Therapeutic Glycoproteins Product Introduction
10.2.5 Hoffmann-La Roche Recent Development
10.3 Genzyme Corp
10.3.1 Genzyme Corp Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
10.3.4 Bio-Therapeutic Glycoproteins Product Introduction
10.3.5 Genzyme Corp Recent Development
10.4 Abbott Laboratories
10.4.1 Abbott Laboratories Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
10.4.4 Bio-Therapeutic Glycoproteins Product Introduction
10.4.5 Abbott Laboratories Recent Development
10.5 Amgen
10.5.1 Amgen Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
10.5.4 Bio-Therapeutic Glycoproteins Product Introduction
10.5.5 Amgen Recent Development
10.6 Biogen
10.6.1 Biogen Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
10.6.4 Bio-Therapeutic Glycoproteins Product Introduction
10.6.5 Biogen Recent Development
10.7 Merck
10.7.1 Merck Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
10.7.4 Bio-Therapeutic Glycoproteins Product Introduction
10.7.5 Merck Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
10.8.4 Bio-Therapeutic Glycoproteins Product Introduction
10.8.5 GlaxoSmithKline Recent Development
10.9 Novartis Pharmaceuticals Corp
10.9.1 Novartis Pharmaceuticals Corp Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
10.9.4 Bio-Therapeutic Glycoproteins Product Introduction
10.9.5 Novartis Pharmaceuticals Corp Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Bio-Therapeutic Glycoproteins Sales Channels
11.2.2 Bio-Therapeutic Glycoproteins Distributors
11.3 Bio-Therapeutic Glycoproteins Customers
12 Market Forecast
12.1 Global Bio-Therapeutic Glycoproteins Sales and Revenue Forecast 2019-2025
12.2 Global Bio-Therapeutic Glycoproteins Sales Forecast by Type
12.3 Global Bio-Therapeutic Glycoproteins Sales Forecast by Application
12.4 Bio-Therapeutic Glycoproteins Forecast by Regions
12.4.1 Global Bio-Therapeutic Glycoproteins Sales Forecast by Regions 2019-2025
12.4.2 Global Bio-Therapeutic Glycoproteins Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Bio-Therapeutic Glycoproteins Product Picture
Table Bio-Therapeutic Glycoproteins Key Market Segments
Table Major Manufacturers Bio-Therapeutic Glycoproteins Covered in This Report
Table Global Bio-Therapeutic Glycoproteins Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Shar by Type 2014-2025
Figure Antisera Figures
Table Major Manufacturers of Antisera
Figure Cytokines Figures
Table Major Manufacturers of Cytokines
Figure Clotting Factors Figures
Table Major Manufacturers of Clotting Factors
Figure Hormones Figures
Table Major Manufacturers of Hormones
Figure Enzymes Figures
Table Major Manufacturers of Enzymes
Figure Enzyme Inhibitors Figures
Table Major Manufacturers of Enzyme Inhibitors
Table Global Bio-Therapeutic Glycoproteins Market Share by Application 2019-2025 (K MT)
Figure Oncology and Haematology Use Case
Figure Diabetes Use Case
Figure Cardiology Use Case
Figure Inflammatory Diseases Use Case
Figure Others Use Case
Figure Bio-Therapeutic Glycoproteins Report Years Considered
Figure Global Bio-Therapeutic Glycoproteins Market Size 2014-2025 (Million US$)
Figure Global Bio-Therapeutic Glycoproteins Sales 2014-2019 (K MT)
Table Global Bio-Therapeutic Glycoproteins Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Bio-Therapeutic Glycoproteins Sales by Regions 2014-2019 (K MT)
Table Global Bio-Therapeutic Glycoproteins Sales Market Share by Regions 2014-2019
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share by Regions 2014-2019
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share by Regions in 2019
Table Global Bio-Therapeutic Glycoproteins Revenue by Regions 2014-2019 (Million US$)
Table Global Bio-Therapeutic Glycoproteins Revenue Market Share by Regions 2014-2019
Figure Global Bio-Therapeutic Glycoproteins Revenue Market Share by Regions 2014-2019
Figure Global Bio-Therapeutic Glycoproteins Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Bio-Therapeutic Glycoproteins Sales by Manufacturers (2014-2019) (K MT)
Table Global Bio-Therapeutic Glycoproteins Sales Share by Manufacturers (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Sales Share by Manufacturers in 2019
Table Bio-Therapeutic Glycoproteins Revenue by Manufacturers (2014-2019) (Million USD)
Table Bio-Therapeutic Glycoproteins Revenue Share by Manufacturers (2014-2019)
Figure Bio-Therapeutic Glycoproteins Value Share by Manufacturers in 2019
Table Global Bio-Therapeutic Glycoproteins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Bio-Therapeutic Glycoproteins Price (2014-2019) (USD/MT)
Table Key Manufacturers Bio-Therapeutic Glycoproteins Plants/Factories Distribution
Table Key Manufacturers Bio-Therapeutic Glycoproteins Area Served
Table Date of Key Manufacturers Enter into Bio-Therapeutic Glycoproteins Market
Table Key Manufacturers Bio-Therapeutic Glycoproteins Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Antisera Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Cytokines Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Clotting Factors Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Hormones Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Enzymes Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Enzyme Inhibitors Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Bio-Therapeutic Glycoproteins Sales by Type (2014-2019) (K MT)
Table Global Bio-Therapeutic Glycoproteins Sales Share by Type (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share by Type in 2018
Table Global Bio-Therapeutic Glycoproteins Revenue by Type (2014-2019) (Million US$)
Table Global Bio-Therapeutic Glycoproteins Revenue Share by Type (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type in 2018
Table Bio-Therapeutic Glycoproteins Price by Type 2014-2019 (USD/MT)
Table Global Bio-Therapeutic Glycoproteins Sales by Application (2014-2019) (K MT)
Table Global Bio-Therapeutic Glycoproteins Sales Share by Application (2014-2019)
Figure Global Sales Bio-Therapeutic Glycoproteins Market Share by Application (2014-2019)
Figure Global Sales Bio-Therapeutic Glycoproteins Market Share by Application (2014-2019)
Figure United States Bio-Therapeutic Glycoproteins Sales Growth Rate 2014-2019 (K MT)
Figure United States Bio-Therapeutic Glycoproteins Revenue Growth Rate 2014-2019 (Million US$)
Table United States Bio-Therapeutic Glycoproteins Sales by Company (2014-2019) (K MT)
Table United States Bio-Therapeutic Glycoproteins Sales Market Share by Company (2014-2019)
Figure United States Bio-Therapeutic Glycoproteins Sales Market Share by Company in 2019
Table United States Bio-Therapeutic Glycoproteins Sales by Type (2014-2019) (K MT)
Table United States Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure United States Bio-Therapeutic Glycoproteins Market Share by Type in 2019
Table United States Bio-Therapeutic Glycoproteins Sales by Application (2014-2019) (K MT)
Table United States Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Figure United States Bio-Therapeutic Glycoproteins Market Share by Application in 2019
Figure European Union Bio-Therapeutic Glycoproteins Sales Growth Rate 2014-2019 (K MT)
Figure European Union Bio-Therapeutic Glycoproteins Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Bio-Therapeutic Glycoproteins Sales by Company (2014-2019) (K MT)
Table European Union Bio-Therapeutic Glycoproteins Sales Market Share by Company (2014-2019)
Figure European Union Bio-Therapeutic Glycoproteins Sales Market Share by Company in 2019
Table European Union Bio-Therapeutic Glycoproteins Sales by Type (2014-2019) (K MT)
Table European Union Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure 2018 European Union Bio-Therapeutic Glycoproteins Market Share by Type
Table European Union Bio-Therapeutic Glycoproteins Sales by Application (2014-2019) (K MT)
Table European Union Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Figure 2018 European Union Bio-Therapeutic Glycoproteins Market Share by Application
Figure China Bio-Therapeutic Glycoproteins Sales Growth Rate 2014-2019 (K MT)
Figure China Bio-Therapeutic Glycoproteins Revenue Growth Rate 2014-2019 (Million US$)
Table China Bio-Therapeutic Glycoproteins Sales by Company (2014-2019) (K MT)
Table China Bio-Therapeutic Glycoproteins Sales Market Share by Company (2014-2019)
Figure China Bio-Therapeutic Glycoproteins Sales Market Share by Company in 2019
Table China Bio-Therapeutic Glycoproteins Sales by Type (2014-2019) (K MT)
Table China Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure China Bio-Therapeutic Glycoproteins Market Share by Type in 2019
Table China Bio-Therapeutic Glycoproteins Sales by Application (2014-2019) (K MT)
Table China Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Figure China Bio-Therapeutic Glycoproteins Market Share by Application in 2019
Figure Rest of World Bio-Therapeutic Glycoproteins Sales Growth Rate 2014-2019 (K MT)
Figure Rest of World Bio-Therapeutic Glycoproteins Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Bio-Therapeutic Glycoproteins Sales by Company (2014-2019) (K MT)
Table Rest of World Bio-Therapeutic Glycoproteins Sales Market Share by Company (2014-2019)
Figure Rest of World Bio-Therapeutic Glycoproteins Sales Market Share by Company in 2019
Table Rest of World Bio-Therapeutic Glycoproteins Sales by Type (2014-2019) (K MT)
Table Rest of World Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure Rest of World Bio-Therapeutic Glycoproteins Market Share by Type in 2019
Table Rest of World Bio-Therapeutic Glycoproteins Sales by Application (2014-2019) (K MT)
Table Rest of World Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Figure Rest of World Bio-Therapeutic Glycoproteins Market Share by Application in 2019
Table Rest of World Bio-Therapeutic Glycoproteins Sales by Countries (2014-2019) (K MT)
Table Rest of World Bio-Therapeutic Glycoproteins Sales Market Share by Countries (2014-2019)
Figure Rest of World Bio-Therapeutic Glycoproteins Sales Market Share by Countries in 2019
Table Rest of World Bio-Therapeutic Glycoproteins Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Bio-Therapeutic Glycoproteins Revenue Market Share by Countries (2014-2019)
Figure Rest of World Bio-Therapeutic Glycoproteins Revenue Market Share by Countries in 2019
Figure Japan Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019) (K MT)
Figure Japan Bio-Therapeutic Glycoproteins Revenue Growth Rate (2014-2019) (K MT)
Figure Korea Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019) (K MT)
Figure Korea Bio-Therapeutic Glycoproteins Revenue Growth Rate (2014-2019) (K MT)
Figure India Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019) (K MT)
Figure India Bio-Therapeutic Glycoproteins Revenue Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2014-2019) (K MT)
Table Genentech Company Details
Table Genentech Description and Business Overview
Table Genentech Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Genentech Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Table Genentech Bio-Therapeutic Glycoproteins Sales Market Share in Global Market
Table Genentech Recent Development
Table Hoffmann-La Roche Company Details
Table Hoffmann-La Roche Description and Business Overview
Table Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Table Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales Market Share in Global Market
Table Hoffmann-La Roche Recent Development
Table Genzyme Corp Company Details
Table Genzyme Corp Description and Business Overview
Table Genzyme Corp Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Genzyme Corp Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Table Genzyme Corp Bio-Therapeutic Glycoproteins Sales Market Share in Global Market
Table Genzyme Corp Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Description and Business Overview
Table Abbott Laboratories Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Abbott Laboratories Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Table Abbott Laboratories Bio-Therapeutic Glycoproteins Sales Market Share in Global Market
Table Abbott Laboratories Recent Development
Table Amgen Company Details
Table Amgen Description and Business Overview
Table Amgen Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Amgen Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Table Amgen Bio-Therapeutic Glycoproteins Sales Market Share in Global Market
Table Amgen Recent Development
Table Biogen Company Details
Table Biogen Description and Business Overview
Table Biogen Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Biogen Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Table Biogen Bio-Therapeutic Glycoproteins Sales Market Share in Global Market
Table Biogen Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Merck Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Table Merck Bio-Therapeutic Glycoproteins Sales Market Share in Global Market
Table Merck Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Novartis Pharmaceuticals Corp Company Details
Table Novartis Pharmaceuticals Corp Description and Business Overview
Table Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Table Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales Market Share in Global Market
Table Novartis Pharmaceuticals Corp Recent Development
Figure Bio-Therapeutic Glycoproteins Value Chain
Table Bio-Therapeutic Glycoproteins Distributors List
Table Bio-Therapeutic Glycoproteins Customers List
Table Global Bio-Therapeutic Glycoproteins Sales Forecast 2019-2025 (K MT) & (Million US$)
Figure Global Bio-Therapeutic Glycoproteins Sales Forecast 2019-2025 (K MT)
Figure Global Bio-Therapeutic Glycoproteins Revenue Forecast 2019-2025 (Million US$)
Table Global Bio-Therapeutic Glycoproteins Sales Forecast by Type 2019-2025 (K MT)
Figure Global Bio-Therapeutic Glycoproteins Sales Forecast by Type 2019-2025 (K MT)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share Forecast by Type 2019-2025
Table Global Bio-Therapeutic Glycoproteins Sales Forecast by Application 2019-2025 (K MT)
Figure Global Bio-Therapeutic Glycoproteins Sales Forecast by Application 2019-2025 (K MT)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share Forecast by Application 2019-2025
Table Global Bio-Therapeutic Glycoproteins Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Bio-Therapeutic Glycoproteins Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share Forecast by Regions 2019-2025
Table Global Bio-Therapeutic Glycoproteins Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Bio-Therapeutic Glycoproteins Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Bio-Therapeutic Glycoproteins Revenue Market Share Forecast by Regions 2019-2025
Figure United States Bio-Therapeutic Glycoproteins Sales Forecast 2019-2025 (K MT)
Figure United States Bio-Therapeutic Glycoproteins Revenue Forecast 2019-2025 (Million US$)
Figure European Union Bio-Therapeutic Glycoproteins Sales Forecast 2019-2025 (K MT)
Figure European Union Bio-Therapeutic Glycoproteins Revenue Forecast 2019-2025 (Million US$)
Figure China Bio-Therapeutic Glycoproteins Sales Forecast 2019-2025 (K MT)
Figure China Bio-Therapeutic Glycoproteins Revenue Forecast 2019-2025 (Million US$)
Figure Japan Bio-Therapeutic Glycoproteins Sales Forecast 2019-2025 (K MT)
Figure Japan Bio-Therapeutic Glycoproteins Revenue Forecast 2019-2025 (Million US$)
Figure Korea Bio-Therapeutic Glycoproteins Sales Forecast 2019-2025 (K MT)
Figure Korea Bio-Therapeutic Glycoproteins Revenue Forecast 2019-2025 (Million US$)
Figure India Bio-Therapeutic Glycoproteins Sales Forecast 2019-2025 (K MT)
Figure India Bio-Therapeutic Glycoproteins Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Sales Forecast 2019-2025 (K MT)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs